Antiviral innate immunity in myocarditis: mechanisms and emerging therapeutics.

Hammons C, Mohanram A, Nguyen P, Lu W, Jacobs B, Li XC, Zhang Z, Xing J

Open source

DOI
10.1038/s12276-026-01822-z
Published
2026 Sep 3
Container
Experimental & molecular medicine
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s12276-026-01822-z,
  title = {Antiviral innate immunity in myocarditis: mechanisms and emerging therapeutics.},
  author = {Hammons C and Mohanram A and Nguyen P and Lu W and Jacobs B and Li XC and Zhang Z and Xing J},
  year = {2026},
  journal = {Experimental \& molecular medicine},
  doi = {10.1038/s12276-026-01822-z},
  url = {https://doi.org/10.1038/s12276-026-01822-z}
}

RIS

TY  - JOUR
TI  - Antiviral innate immunity in myocarditis: mechanisms and emerging therapeutics.
AU  - Hammons C
AU  - Mohanram A
AU  - Nguyen P
AU  - Lu W
AU  - Jacobs B
AU  - Li XC
AU  - Zhang Z
AU  - Xing J
PY  - 2026
JO  - Experimental & molecular medicine
DO  - 10.1038/s12276-026-01822-z
UR  - https://doi.org/10.1038/s12276-026-01822-z
ER  - 

APA

C, H., A, M., P, N., W, L., B, J., XC, L., Z, Z., & J, X. (2026). Antiviral innate immunity in myocarditis: mechanisms and emerging therapeutics.. Experimental & molecular medicine. https://doi.org/10.1038/s12276-026-01822-z

Source records